News Breaks |
|
|
| January 3, 2013 |
| 19:12 EDT |  | SGMO | Sangamo BioSciences upgraded to Overweight from Underweight at Piper Jaffray
Piper Jaffray upgraded Sangamo BioSciences two notches to Overweight from Underweight and raised its price target for shares to $10 from $4 after assuming coverage of the stock. Piper says the company has a broad gene therapy platform with increasing visibility. |
|
|
News For SGMO From The Last 14 Days Check below for free stories on SGMO the last two weeks. |
|
|
| May 21, 2013 |
| 11:41 EDT |  | SGMO | Options with decreasing implied volatility: SGMO WCRX NTI TSLA AMRN
|
|
| May 20, 2013 |
| 11:56 EDT | | SGMO | Options with decreasing implied volatility: SGMO WCRX TSLA CSC SUPN
|
|
| 07:01 EDT |  | SGMO | Sangamo BioSciences announces positive data for Vivo Protein platform
Sangamo BioSciences (SGMO) announced the presentation of new data demonstrating the successful application of Sangamo's proprietary In Vivo Protein Replacement Platform to produce therapeutically relevant levels of Factor VIII in a mouse model. Sangamo has partnered with Shire (SHPG) to develop ZFP Therapeutics for both hemophilia A and B using this approach. |
|
| May 17, 2013 |
| 11:53 EDT | | SGMO | Options with decreasing implied volatility: SGMO ARNA CSC ENDP
 Subscribe for More Information |
|
| May 16, 2013 |
| 11:27 EDT | | SGMO | Options with decreasing implied volatility: LNCO MBI OPK THRX SGMO
Subscribe for More Information |
|
| May 15, 2013 |
| 11:13 EDT | | SGMO | Options with decreasing implied volatility: MM GMCR GRPN THRX SGMO
Subscribe for More Information |
|
| 10:43 EDT | | SGMO | Sangamo BioSciences drops 10% after announcing HIV study data
Subscribe for More Information |
|
| 10:06 EDT | | SGMO | Sangamo BioSciences to present new data on HIV/AIDS candidate
Subscribe for More Information |
|
| May 14, 2013 |
| 11:44 EDT | | SGMO | Options with decreasing implied volatility: GRPN MAKO GMCR EZCH SGMO
|
|
| May 10, 2013 |
| 11:27 EDT | | SGMO | Options with decreasing implied volatility: MBI SGMO ALGN GMCR EZCH
|
| |
| May 8, 2013 |
| 16:12 EDT |  | SGMO | Sangamo BioSciences backs FY13 revenue $20M-$24M, consensus $20.7M
|
|
| 16:11 EDT | | SGMO | Sangamo BioSciences reports Q1 EPS (13c), consensus (16c)
Subscribe for More Information |
|
|
|
|
|
